Search - tctmd.com

Displaying 161 - 180 of 471

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

News Daily News

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

Caitlin E. Cox

October 27, 2022

News Daily News

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

Todd Neale

October 26, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Conference News HFSA 2022

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

Yael L. Maxwell

October 07, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Todd Neale

September 26, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

VITAL Rhythm Data May Flip the Script on AF Screening in Women

L.A. McKeown

September 08, 2022

News Daily News

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

Yael L. Maxwell

September 02, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

Advertisement

November 2022 News Roundup

TCTMD’s Top 10 Most Popular Stories for October 2022

From Cannabis to Opioids, Meth, and Cocaine: Drugs Are Linked to More AF

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

New Biomarker-Based Risk Score Performs Well in ACS

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

No Benefit of LAA Ligation During HeartMate 3 Implantation: MOMENTUM 3

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

October 2022 News Roundup

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Most Patient-Reported Outcome Measures in CVD Fall Short

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

VITAL Rhythm Data May Flip the Script on AF Screening in Women

Stable Chest Pain Guideline Data Standards Developed to Add Uniformity

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

What’s Going to Be Hot at ESC 2022?

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content